AbbVie (ABBV) Goodwill (2012 - 2026)
AbbVie (ABBV) reported Goodwill of $35.6 billion for Q1 2026, up 0.81% year-over-year from $35.3 billion in Q1 2025, and little changed quarter-over-quarter from $35.6 billion in Q4 2025.
AbbVie (ABBV) Goodwill (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has 15 years of Goodwill data on file, last reported at $35.6 billion in Q1 2026.
- Goodwill for Q1 2026 came in at $35.6 billion, up 0.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.6 billion (up 0.81% YoY), and the FY2025 annual result was $35.6 billion, up 1.96% from the prior year.
- Goodwill steadied at $35.6 billion in Q1 2026 per ABBV's latest filing, from $35.6 billion in the prior quarter.
- Over five years, Goodwill peaked at $35.6 billion in Q4 2025 and troughed at $31.7 billion in Q3 2022.
- A 5-year average of $33.6 billion and a median of $33.4 billion in 2024 frame the typical range for Goodwill.
- The sharpest annual moves came in 2022 and 2024: Goodwill slipped 1.76% in 2022, then grew 9.98% in 2024.
- A 5-year view of Goodwill shows it stood at $32.2 billion in 2022, then climbed by 0.43% to $32.3 billion in 2023, then increased by 8.25% to $35.0 billion in 2024, then increased by 1.96% to $35.6 billion in 2025, then slipped by 0.2% to $35.6 billion in 2026.
- Business Quant data shows ABBV's Goodwill at $35.6 billion in Q1 2026, $35.6 billion in Q4 2025, and $35.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.57 Bn |
| Dec 31, 2025 | 35.64 Bn |
| Sep 30, 2025 | 35.63 Bn |
| Jun 30, 2025 | 35.64 Bn |
| Mar 31, 2025 | 35.29 Bn |
| Dec 31, 2024 | 34.96 Bn |
| Sep 30, 2024 | 35.30 Bn |
| Jun 30, 2024 | 33.39 Bn |
| Mar 31, 2024 | 33.43 Bn |
| Dec 31, 2023 | 32.29 Bn |
| Sep 30, 2023 | 32.09 Bn |
| Jun 30, 2023 | 32.22 Bn |
| Mar 31, 2023 | 32.22 Bn |
| Dec 31, 2022 | 32.16 Bn |
| Sep 30, 2022 | 31.73 Bn |
| Jun 30, 2022 | 32.03 Bn |
| Mar 31, 2022 | 32.30 Bn |
| Dec 31, 2021 | 32.38 Bn |
| Sep 30, 2021 | 32.30 Bn |
| Jun 30, 2021 | 32.40 Bn |